Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: Male
Age: 18 - 70+
Code: NCT03861676
Early_phase1, Recruiting
Use of Pedometer Following Radical Prostatectomy
for
Prostate Cancer, Ambulation Difficulty
Location: Seattle WA
Sponsor: Benaroya Research Institute
Sex: Male
Age: 18 - 70+
Code: NCT04206280
Recruiting
Is Adaptive SBRT for Prostate vs Image-guided Radiotherapy a True Evolution (ASPIRE)
for
Localized Prostate Cancer, Stereotactic Body Radiotherapy
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: Male
Age: 18+
Code: NCT06825091
Phase3, Recruiting
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
for
Prostate Cancer, Prostate Cancer (Adenocarcinoma),
Location: Boston MA
Sponsor: Shehzad Basaria, M.D.
Sex: Male
Age: 40+
Code: NCT06957691
Phase2, Recruiting
Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance
Radiation Therapy Approaches for People With Prostate Cancer
for
Prostate Cancer Patients, Non-metastatic Prostate Cancer,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 0+
Code: NCT07751159
Phase2, Recruiting
Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: Male
Age: 18+
Code: NCT05613894
Phase1, Recruiting
MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer